Pathology Services Global Market Report 2026

Pathology services are specialized diagnostic healthcare services focused on examining biological samples, body fluids, and tissues to identify diseases and medical conditions. These services assist healthcare providers in accurately diagnosing illnesses, tracking disease progression, and selecting suitable treatment approaches. Pathology services are essential for the detection of cancer, infectious diseases, genetic abnormalities, and chronic health conditions while also supporting preventive care and personalized medicine initiatives.

The primary service categories of pathology services include clinical pathology, anatomical pathology, molecular pathology, cytopathology, and forensic pathology. Clinical pathology refers to laboratory-based medical services that focus on the examination of bodily fluids such as blood, urine, and other specimens to diagnose, monitor, and treat diseases. These services are classified by test type, including blood testing, urine testing, tissue biopsy testing, genetic testing, microbiological testing, and immunological testing, and are supported by technologies such as laboratory automation, digital pathology, molecular diagnostic technologies, and artificial intelligence with data analytics. Their applications include disease diagnosis, drug discovery and development, and other related uses, while the key end users comprise hospitals, diagnostic laboratories, research institutions, physician offices, and homecare settings.

Tariffs are influencing the pathology services market by increasing the cost of imported diagnostic reagents, laboratory instruments, testing kits, and advanced molecular pathology equipment used in both clinical and research applications. This is slowing laboratory expansion and driving up operational expenses, particularly in import-dependent regions such as Asia-Pacific and Latin America. Segments such as molecular pathology, anatomical pathology, and laboratory automation under technology are most affected due to their reliance on globally sourced high-end systems and consumables. However, tariffs are also promoting domestic production of diagnostic kits, diversification of regional suppliers, and greater investment in local laboratory infrastructure, ultimately strengthening long-term resilience and self-sufficiency in pathology service delivery.

The pathology services market size has grown strongly in recent years. It will grow from $33.78 billion in 2025 to $36.14 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to dependence on manual laboratory testing procedures, limited automation in diagnostic workflows, low adoption of molecular diagnostic technologies, shortage of skilled laboratory personnel, and fragmented healthcare laboratory infrastructure.

The pathology services market size is expected to see strong growth in the next few years. It will grow to $47.79 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to AI-enabled diagnostic interpretation systems, expansion of precision medicine adoption, growth in cloud-based pathology platforms, increasing demand for preventive healthcare screening, and integration of multi-omics and advanced molecular testing approaches. Major trends in the forecast period include rising adoption of molecular and genetic testing for precision diagnostics, increasing shift toward integrated laboratory automation in pathology workflows, expansion of decentralized and point-of-care pathology testing services, growing demand for multi-omics-based disease detection methods, and increasing use of predictive analytics for early disease identification and continuous monitoring.

The expansion of personalized and precision medicine is expected to propel the growth of the pathology services market going forward. Personalized and precision medicine refers to a healthcare approach that customizes disease prevention, diagnosis, and treatment based on an individual's unique genetic, molecular, and clinical profile. The increasing adoption of precision medicine is mainly fueled by rapid progress in genomic sequencing technologies, which have substantially lowered the cost and time required to generate patient-specific genetic data, enabling wider clinical use across healthcare systems. The growing expansion of personalized and precision medicine increases demand for pathology services, as they are crucial for performing genetic testing, biomarker evaluation, and molecular diagnostics that support individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six in 2022. Therefore, the expansion of personalized and precision medicine is driving the growth of the pathology services market.

Leading companies operating in the pathology services market are focusing on expanding artificial intelligence (AI)-powered digital pathology solutions to improve diagnostic precision, streamline laboratory workflows, and support pathologists in disease detection and analysis. AI-powered digital pathology solutions refer to advanced technologies that combine digital imaging, cloud-based platforms, and machine learning algorithms to assist in pathology interpretation, case review, and clinical decision-making. For example, in February 2026, Laboratory Corporation of America Holdings, a US-based life sciences and diagnostic company, expanded its collaboration with PathAI, a US-based biotechnology company, to deploy the AISight Dx, an FDA-cleared digital pathology image management system, across its laboratory network. It supports digital pathology workflows through case management, slide annotation, real-time collaboration, and seamless integration with laboratory information systems. The platform combines AI-driven image analysis with secure and scalable infrastructure to improve diagnostic accuracy, reduce manual errors, and enhance operational efficiency.

In July 2024, Quest Diagnostics, a US-based provider of diagnostic information services, laboratory testing, and pathology services, acquired the laboratory assets of PathAI Diagnostics from PathAI for an undisclosed amount. Through this acquisition, Quest Diagnostics aims to accelerate the integration of artificial intelligence and digital pathology technologies to improve cancer diagnosis and further enhance diagnostic efficiency and accuracy. PathAI is a US-based provider of digital and artificial intelligence-enabled pathology laboratory services focused on advancing precision diagnostics and supporting clinical applications as well as biopharmaceutical research.

Major companies operating in the pathology services market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, Charles River Laboratories International Inc., Healius Limited, ARUP Laboratories Inc., Apollo Diagnostics, Mayo Clinic Laboratories, Fulgent Genetics Inc., ACL Laboratories, Spectrum Healthcare Partners P.A., MedGenome Labs Ltd., ACM Global Laboratories Inc., Guangzhou KingMed Diagnostics Group Co. Ltd., Krsnaa Diagnostics Limited, Synnovis Group LLP, Dr Lal PathLabs, SYNLAB, Unilabs

North America was the dominant region in the pathology services market in 2025. Asia-Pacific is expected to be the rapidly expanding regionin the forecast period. The regions covered in the pathology services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pathology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pathology services market includes revenues earned by entities by providing services such as laboratory testing, diagnostic analysis, specimen collection, histopathology, and consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering, such as diagnostic kits, reagents, and testing consumables. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pathology services market research report is one of a series of new reports from The Business Research Company that provides pathology services market statistics, including pathology services industry global market size, regional shares, competitors with a pathology services market share, detailed pathology services market segments, market trends and opportunities, and any further data you may need to thrive in the pathology services industry. This pathology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pathology Services Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pathology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pathology services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pathology services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Service Type: Clinical Pathology; Anatomical Pathology; Molecular Pathology; Cytopathology; Forensic Pathology
• 2) By Test Type: Blood Testing; Urine Testing; Tissue Biopsy Testing; Genetic Testing; Microbiological Testing; Immunological Testing
• 3) By Technology: Laboratory Automation; Digital Pathology; Molecular Diagnostics Technologies; Artificial Intelligence And Data Analytics
• 4) By Application: Disease Diagnosis; Drug Discovery And Development; Other Applications
• 5) By End User: Hospitals; Diagnostic Laboratories; Research Institutions; Physician Offices; Homecare Settings
• Subsegments:
• 1) By Clinical Pathology: Hematology Testing; Clinical Chemistry; Microbiology Testing; Immunology And Serology; Coagulation Testing; Urinalysis; Toxicology Testing; Blood Banking And Transfusion Services
• 2) By Anatomical Pathology: Histopathology; Surgical Pathology; Dermatopathology; Neuropathology; Gastrointestinal Pathology; Renal Pathology; Gynecological Pathology; Autopsy Pathology
• 3) By Molecular Pathology: Polymerase Chain Reaction (PCR) Testing; Next-Generation Sequencing (NGS); Genetic Testing; Companion Diagnostics; Infectious Disease Molecular Diagnostics; Oncology Molecular Diagnostics; Pharmacogenomics Testing; Prenatal Molecular Testing
• 4) By Cytopathology: Gynecologic Cytology; Non-Gynecologic Cytology; Fine Needle Aspiration (FNA) Cytology; Exfoliative Cytology; Liquid-Based Cytology; Urine Cytology; Respiratory Cytology; Breast Cytology
• 5) By Forensic Pathology: Postmortem Examination; Toxicological Analysis; Forensic Histopathology; Deoxyribonucleic Acid Profiling; Ballistic And Trauma Analysis; Sudden Death Investigation; Forensic Anthropology; Medico-Legal Investigation
• Companies Mentioned: Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Sonic Healthcare Limited; Charles River Laboratories International Inc.; Healius Limited; ARUP Laboratories Inc.; Apollo Diagnostics; Mayo Clinic Laboratories; Fulgent Genetics Inc.; ACL Laboratories; Spectrum Healthcare Partners P.A.; MedGenome Labs Ltd.; ACM Global Laboratories Inc.; Guangzhou KingMed Diagnostics Group Co. Ltd.; Krsnaa Diagnostics Limited; Synnovis Group LLP; Dr Lal PathLabs; SYNLAB; Unilabs
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.